ARTICLE | Company News
CPMP positive on Novartis' Starlix
January 29, 2001 8:00 AM UTC
Europe's CPMP gave a positive opinion to NVS's Starlix nateglinide to treat Type II diabetes in combination with metformin. The product, a D-phenylalanine derivative, is approved in the U.S., Japan, S...